Bernard Castelain
Overview
Explore the profile of Bernard Castelain including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
325
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pasquier D, Boutaud de la Combe-Chossiere L, Carlier D, Darloy F, Degrendel-Courtecuisse A, Dufour C, et al.
PLoS One
. 2016 Mar;
11(3):e0150917.
PMID: 26987121
Background: Inter-observer delineation variation has been detailed for many years in almost every tumor location. Inadequate delineation can impair the chance of cure and/or increase toxicity. The aim of our...
2.
Cordoba A, Nickers P, Tresch E, Castelain B, Leblanc E, Narducci F, et al.
Rep Pract Oncol Radiother
. 2015 Nov;
20(5):385-92.
PMID: 26549997
Aim: To report a single-institution experience using postoperative pelvic Intensity Modulation Radiation Therapy (IMRT) using tomotherapy accelerators (TA) in postoperative endometrial cancer (EC) regarding ICRU 83 recommendations. Background: IMRT in...
3.
Refaat T, Castelain B, Small Jr W, Elsaid A, Lotfy N, Lartigau E, et al.
Am J Clin Oncol
. 2013 Jun;
38(3):289-93.
PMID: 23799285
Purpose: Concurrent chemoradiotherapy (CRT) is the standard of care for patients with bulky cervical cancer. This study aimed to determine the feasibility, tolerance, and effectiveness of pulsed dose rate (PDR)...
4.
Levitchi M, Charra-Brunaud C, Quetin P, Haie-Meder C, Kerr C, Castelain B, et al.
Radiother Oncol
. 2012 May;
103(3):314-21.
PMID: 22633813
Background And Purpose: To assess the association between dosimetric/clinical parameters and gastrointestinal/urinary grade 2-4 side effects in cervix cancer patients treated with 3D pulse dose rate brachytherapy. Materials And Methods:...
5.
Charra-Brunaud C, Harter V, Delannes M, Haie-Meder C, Quetin P, Kerr C, et al.
Radiother Oncol
. 2012 May;
103(3):305-13.
PMID: 22633469
Purpose: In 2005 a French multicentric non randomized prospective study was initiated to compare two groups of patients treated for cervix carcinoma according to brachytherapy (BT) method: 2D vs 3D...
6.
Dewas S, Bibault J, Mirabel X, Nickers P, Castelain B, Lacornerie T, et al.
Radiat Oncol
. 2011 Jun;
6:77.
PMID: 21699690
Background: The first-line treatment of a pelvic recurrence in a previously irradiated area is surgery. Unfortunately, few patients are deemed operable, often due to the location of the recurrence, usually...
7.
Leblanc E, Narducci F, Frumovitz M, Lesoin A, Castelain B, Baranzelli M, et al.
Gynecol Oncol
. 2007 Jan;
105(2):304-11.
PMID: 17258799
Background: Although cervical cancer is clinically staged, surgery has long been considered the best means to assess extrapelvic disease and remains the gold standard for the detection of both intraperitoneal...
8.
Pasquier D, Mirabel X, Adenis A, Rezvoy N, Hecquet G, Fournier C, et al.
Int J Radiat Oncol Biol Phys
. 2006 Jul;
65(5):1456-61.
PMID: 16863928
Purpose: The aim of this study was to retrospectively evaluate the feasibility, efficacy, and tolerance of external beam radiotherapy followed by high-dose-rate brachytherapy in inoperable patients with superficial esophageal cancer....
9.
Knobel D, Zouhair A, Tsang R, Poortmans P, Belkacemi Y, Bolla M, et al.
BMC Cancer
. 2006 May;
6:118.
PMID: 16677383
Background: Solitary plasmacytoma (SP) of the bone is a rare plasma-cell neoplasm. There are no conclusive data in the literature on the optimal radiation therapy (RT) dose in SP. Therefore,...
10.
Narducci F, Sabban F, Vanlerenberghe E, Lesoin A, Chevalier A, Gauthier H, et al.
Bull Cancer
. 2006 Feb;
93(1):43-9.
PMID: 16455505
General tendency of modern cancerology is the research of adequacy between extent of disease and treatments. This concept is of course valid for gynaecology and we saw these last months...